AstraZeneca Pharma gains after signing LOI with Strand Life Sciences
Mumbai, Nov. 17 -- Strand Life Sciences is a genomics research and diagnostics company and a subsidiary of Reliance Industries. AstraZeneca Pharma India clarified that Strand is not a related party and that the execution of the LOI does not constitute a related party transaction.
The company said the proposed engagement reflects its commitment to addressing barriers to timely diagnosis and transforming cancer care for patients across India through strategic partnerships.
AstraZeneca is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines in four areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Rare Diseases. It operates in over 100 countries.
The...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.